Today marks Rare Disease Day 2025. This time last year we published an Article entitled “ Why do we care about rare? ”, summarising the origins of rare disease day, the fundamental ambition – to ...

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés ...

A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational ...

Join us for an online CERSI-PGx Health Economics Workshop on 10 June 2025, from 13:00–17:00 BST, with experts from NHS ...

The NHS’ long term survival is at stake – the Ten Year Plan demonstrates the government’s commitment to invest in its recovery, but in order to truly tackle the existential issues at the heart of the ...

Adopt a prevention-first mindset and provide robust funding for adult vaccination programs Now, more than ever, healthcare systems must invest in strategies to cope with unprecedented and growing ...

Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs and health-focused policies could help boost productivity, reduce costs, and ...

The value of antibiotics often extends beyond what HTA captures. The STEDI framework aims to capture that broader value and our report outlines a roadmap to realising its full potential. Key Takeaways ...

Within this report, we summarise the Digital Health Landscape in the UK. We include areas of regulation, value assessment and reimbursement, and efforts to increase the digital literacy of the general ...

In this report, we describe the design of a globally aligned, value-based, fully-delinked pull incentive, where payers provide manufacturers with a pre-specified subscription fee based on the value of ...

Alzheimer’s Research UK commissioned OHE Consulting to model the incidence and cost of dementia in the UK and the potential impact of better treatment. The analyses estimate the extent of the ...